2-[(5S)-2-(4-bromophenyl)sulfonylimino-4-oxo-3-prop-2-enyl-1,3-thiazolidin-5-yl]-N-(4-chlorophenyl)acetamide

C20H17BrClN3O4S2 — CID 98156976

IUPAC2-[(5S)-2-(4-bromophenyl)sulfonylimino-4-oxo-3-prop-2-enyl-1,3-thiazolidin-5-yl]-N-(4-chlorophenyl)acetamide
SMILESC=CCN1C(=O)[C@H](CC(=O)Nc2ccc(Cl)cc2)SC1=NS(=O)(=O)c1ccc(Br)cc1
InChIInChI=1S/C20H17BrClN3O4S2/c1-2-11-25-19(27)17(12-18(26)23-15-7-5-14(22)6-8-15)30-20(25)24-31(28,29)16-9-3-13(21)4-10-16/h2-10,17H,1,11-12H2,(H,23,26)/t17-/m0/s1
InChIKeyYUVNHTLVEDYLNS-KRWDZBQOSA-N
MW542.86 g/mol
LogP4.31
Rot. Bonds7

About 2-[(5S)-2-(4-bromophenyl)sulfonylimino-4-oxo-3-prop-2-enyl-1,3-thiazolidin-5-yl]-N-(4-chlorophenyl)acetamide

2-[(5S)-2-(4-bromophenyl)sulfonylimino-4-oxo-3-prop-2-enyl-1,3-thiazolidin-5-yl]-N-(4-chlorophenyl)acetamide (PubChem CID 98156976) has the molecular formula C20H17BrClN3O4S2 and a molecular weight of 542.86 g/mol. Its IUPAC name is 2-[(5S)-2-(4-bromophenyl)sulfonylimino-4-oxo-3-prop-2-enyl-1,3-thiazolidin-5-yl]-N-(4-chlorophenyl)acetamide.

Molecular Properties

Compound Name2-[(5S)-2-(4-bromophenyl)sulfonylimino-4-oxo-3-prop-2-enyl-1,3-thiazolidin-5-yl]-N-(4-chlorophenyl)acetamide
PubChem CID98156976
Molecular FormulaC20H17BrClN3O4S2
Molecular Weight542.86 g/mol
Exact Mass540.95
IUPAC Name2-[(5S)-2-(4-bromophenyl)sulfonylimino-4-oxo-3-prop-2-enyl-1,3-thiazolidin-5-yl]-N-(4-chlorophenyl)acetamide
SMILESC=CCN1C(=O)[C@H](CC(=O)Nc2ccc(Cl)cc2)SC1=NS(=O)(=O)c1ccc(Br)cc1
InChIInChI=1S/C20H17BrClN3O4S2/c1-2-11-25-19(27)17(12-18(26)23-15-7-5-14(22)6-8-15)30-20(25)24-31(28,29)16-9-3-13(21)4-10-16/h2-10,17H,1,11-12H2,(H,23,26)/t17-/m0/s1
InChIKeyYUVNHTLVEDYLNS-KRWDZBQOSA-N
XLogP4.31
TPSA95.91 Ų
H-Bond Donors1
H-Bond Acceptors5
Rotatable Bonds7
Heavy Atoms31
Complexity

Lipinski Rule of Five

1 violation

RuleValue
MW ≤ 500542.86
LogP ≤ 54.31
H-Bond Donors ≤ 51
H-Bond Acceptors ≤ 105

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'imine_1', 'substructure': 'N/A'}, {'alert_name': 'isolated_alkene', 'substructure': 'N/A'}

Analyze 2-[(5S)-2-(4-bromophenyl)sulfonylimino-4-oxo-3-prop-2-enyl-1,3-thiazolidin-5-yl]-N-(4-chlorophenyl)acetamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of 2-[(5S)-2-(4-bromophenyl)sulfonylimino-4-oxo-3-prop-2-enyl-1,3-thiazolidin-5-yl]-N-(4-chlorophenyl)acetamide?
The IUPAC name of 2-[(5S)-2-(4-bromophenyl)sulfonylimino-4-oxo-3-prop-2-enyl-1,3-thiazolidin-5-yl]-N-(4-chlorophenyl)acetamide (CID 98156976) is 2-[(5S)-2-(4-bromophenyl)sulfonylimino-4-oxo-3-prop-2-enyl-1,3-thiazolidin-5-yl]-N-(4-chlorophenyl)acetamide.
What is the SMILES notation for 2-[(5S)-2-(4-bromophenyl)sulfonylimino-4-oxo-3-prop-2-enyl-1,3-thiazolidin-5-yl]-N-(4-chlorophenyl)acetamide?
The canonical SMILES for 2-[(5S)-2-(4-bromophenyl)sulfonylimino-4-oxo-3-prop-2-enyl-1,3-thiazolidin-5-yl]-N-(4-chlorophenyl)acetamide is C=CCN1C(=O)[C@H](CC(=O)Nc2ccc(Cl)cc2)SC1=NS(=O)(=O)c1ccc(Br)cc1.
What is the InChIKey of 2-[(5S)-2-(4-bromophenyl)sulfonylimino-4-oxo-3-prop-2-enyl-1,3-thiazolidin-5-yl]-N-(4-chlorophenyl)acetamide?
The InChIKey is YUVNHTLVEDYLNS-KRWDZBQOSA-N. The full InChI is InChI=1S/C20H17BrClN3O4S2/c1-2-11-25-19(27)17(12-18(26)23-15-7-5-14(22)6-8-15)30-20(25)24-31(28,29)16-9-3-13(21)4-10-16/h2-10,17H,1,11-12H2,(H,23,26)/t17-/m0/s1.
What are the key properties of 2-[(5S)-2-(4-bromophenyl)sulfonylimino-4-oxo-3-prop-2-enyl-1,3-thiazolidin-5-yl]-N-(4-chlorophenyl)acetamide?
2-[(5S)-2-(4-bromophenyl)sulfonylimino-4-oxo-3-prop-2-enyl-1,3-thiazolidin-5-yl]-N-(4-chlorophenyl)acetamide has a molecular weight of 542.86 g/mol, XLogP of 4.31, 7 rotatable bonds, 1 hydrogen bond donors, and 5 hydrogen bond acceptors.
Where does this data come from?
All data for 2-[(5S)-2-(4-bromophenyl)sulfonylimino-4-oxo-3-prop-2-enyl-1,3-thiazolidin-5-yl]-N-(4-chlorophenyl)acetamide is sourced from PubChem (CID 98156976), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).